CLINICAL_TRIALS
trial_result
· 2017-04-04
Clinical Trial Update: Essentiality of INH in TB Therapy [Phase 2]
Summary
This Phase 2 clinical trial update evaluates the essential role of isoniazid (INH) in tuberculosis therapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04